Fireside Chat: Keeping Cambridge/Boston the Center of Innovation

It’s been a rough several months for the Cambridge/Boston biotech ecosystem—especially for scientists in academia and industry working on rare diseases, genetic medicines, and advanced therapies. This fireside chat convenes biotech leaders, patient advocates, scientists, and providers of innovation and services to candidly unpack the headwinds of policy uncertainties, and constrained funding.

Together, we’ll identify practical, near-term actions the community can take, outline where partners can step in to fill critical gaps, and kick off an ongoing, solutions-focused conversation to keep Cambridge/Boston at the forefront of biomedical innovation.

What we’ll cover

• The current policy and funding landscape—and what it means for Cambridge/Boston Life Sciences, rare disease, genetic medicines, and advanced therapy pipelines
• High-impact ways industry, academia, and service/innovation partners can collaborate to de-risk R&D
• Concrete supports for scientists and teams (shared resources, bridge funding models, trial enablement, regulatory readiness)
• The role of patient organizations in shaping priorities, access, and sustained momentum
• A community call-to-action to safeguard Cambridge/Boston’s innovation leadership

Host or Publisher Pace® Life Sciences